Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Current Directions in Biomedical Engineering

Joint Journal of the German Society for Biomedical Engineering in VDE and the Austrian and Swiss Societies for Biomedical Engineering

Editor-in-Chief: Dössel, Olaf

Editorial Board: Augat, Peter / Buzug, Thorsten M. / Haueisen, Jens / Jockenhoevel, Stefan / Knaup-Gregori, Petra / Kraft, Marc / Lenarz, Thomas / Leonhardt, Steffen / Malberg, Hagen / Penzel, Thomas / Plank, Gernot / Radermacher, Klaus M. / Schkommodau, Erik / Stieglitz, Thomas / Urban, Gerald A.

1 Issue per year

Open Access
Online
ISSN
2364-5504
See all formats and pricing
More options …

QRS and QT ventricular conduction times and permanent pacemaker therapy after transcatheter aortic valve implantation

P.C. Takam
  • Corresponding author
  • University of Applied Sciences Offenburg, Department Biomedical Engineering, Offenburg, Germany
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ D. Höfflin / M. Heinke
  • University of Applied Sciences Offenburg, Department Biomedical Engineering, Offenburg, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2015-09-12 | DOI: https://doi.org/10.1515/cdbme-2015-0032

Abstract

Transcatheter aortic valve implantation is a therapy for patients with reduced left ventricular ejection fraction and symptomatic aortic stenosis. The aim of the study was to compare the pre-and post- transcatheter aortic valve implantation procedures to determine the QRS and QT ventricular conduction times as a potential predictor of permanent pacemaker therapy requirement after transcatheter aortic valve implantation. QRS and QT ventricular conduction times were prolonged after transcatheter aortic valve implantation in heart failure patients with permanent dual chamber pacemaker therapy after transcatheter aortic valve implantation. QRS and QT ventricular conduction times may be useful parameters to evaluate the risk of post-procedural ventricular conduction block and permanent pacemaker therapy in transcatheter aortic valve implantation.

1 Introduction

Transcatheter aortic valve implantation is a successful therapy for patients with reduced left ventricular ejection fraction and symptomatic aortic stenosis [1, 2]. The aim of the study was to compare the pre-and post- transcatheter aortic valve implantation procedures to determine the QRS and QT ventricular conduction times as a potential predictor of permanent pacemaker therapy requirement after transcatheter aortic valve implantation.

2 Methods

Transcatheter aortic valve implantation patients were divided into groups without pacemaker and with dual or single chamber pacemaker with different QRS complex and QT ventricular conduction times disturbance before and after transcatheter aortic valve implantation.

Electrical QRS duration and QT duration were evaluated with surface ECG before transcathter aortic valve implantation in patients with dual or single chamber pacemaker after transcatheter aortic valve implantation.

QRS duration was measured between onset and offset of the QRS complex in the surface ECG. QT interval was measured between onset of the QRS complex and offset of the T wave in the surface ECG in 536 high-risk patients before and after transcatheter aortic valve implantation. The mean age of the heart failure patients (314 females and 222 males) was 82.95±5.82 years with 2.9±0.53 New York Association functional class.

Statistical analysis were performed by Origin 9.1 software (OriginLab Cooperation, Northampton, MA, USA) using paired and unpaired t-test, as appropriated, with a statistical significance of p < 0.005 and with Pearson correlation coefficients.

3 Results

3.1 Left ventricular ejection fraction

Left ventricular ejection fraction increased from 41±13.29 % before implantation to 42.3±7.22 % after transcatheter aortic valve implantation (p = 0.02) (Fig. 1).

3.2 Cardiac pacemaker after transcatheter aortic valve implantation

Electrical ventricle conduction QRS time correlated with atrioventricular conduction PQ time and heart period duration before (Fig. 2) and after transcatheter aortic valve implantation (p = 0.02) (Fig. 3).

Electrical ventricular conduction QT time correlated with atrioventricular conduction PQ time (p = 0.04) and with heart period duration before transcatheter aortic

Box diagram of feft ventricular ejection fraction before and after transcatheter aortic valve implantation. LVEF - Left ventricular ejection fraction.
Figure 1

Box diagram of feft ventricular ejection fraction before and after transcatheter aortic valve implantation. LVEF - Left ventricular ejection fraction.

QRS duration, heart period duration and atrioventricular conduction time before transcatheter aortic valve implantation (TAVI) and single chamber ventricular pacemaker. QRS-Prä - ventricular conduction time before TAVI, HPD-Prä – heart period duration after TAVI, PQ-Prä – atrioventricular conduction time after TAVI, r, P – Pearson correlation coefficients.
Figure 2

QRS duration, heart period duration and atrioventricular conduction time before transcatheter aortic valve implantation (TAVI) and single chamber ventricular pacemaker. QRS-Prä - ventricular conduction time before TAVI, HPD-Prä – heart period duration after TAVI, PQ-Prä – atrioventricular conduction time after TAVI, r, P – Pearson correlation coefficients.

QRS duration, heart period duration and atrioventricular conduction time after transcatheter aortic valve implantation (TAVI) and single chamber ventricular pacemaker. QRS-Prä - ventricular conduction time before TAVI, HPD-Prä – heart period duration after TAVI, PQ-Prä – atrioventricular conduction time after TAVI, r, P – Pearson correlation coefficients.
Figure 3

QRS duration, heart period duration and atrioventricular conduction time after transcatheter aortic valve implantation (TAVI) and single chamber ventricular pacemaker. QRS-Prä - ventricular conduction time before TAVI, HPD-Prä – heart period duration after TAVI, PQ-Prä – atrioventricular conduction time after TAVI, r, P – Pearson correlation coefficients.

QT duration, heart period duration and atrioventricular conduction time before transcatheter aortic valve implantation (TAVI) and single chamber ventricular pacemaker. QRS-Prä - ventricular conduction time bevor TAVI, HPD-Prä – heart period duration after TAVI, PQ-Prä – atrioventricular conduction time after TAVI, r, P – Pearson correlation coefficients.
Figure 4

QT duration, heart period duration and atrioventricular conduction time before transcatheter aortic valve implantation (TAVI) and single chamber ventricular pacemaker. QRS-Prä - ventricular conduction time bevor TAVI, HPD-Prä – heart period duration after TAVI, PQ-Prä – atrioventricular conduction time after TAVI, r, P – Pearson correlation coefficients.

QT duration, heart period duration and atrioventricular conduction time after transcatheter aortic valve implantation (TAVI) and single chamber ventricular pacemaker. QRS-Prä - ventricular conduction time bevor TAVI, HPD-Prä – heart period duration after TAVI, PQ-Prä – atrioventricular conduction time after TAVI, r, P – Pearson correlation coefficients.
Figure 5

QT duration, heart period duration and atrioventricular conduction time after transcatheter aortic valve implantation (TAVI) and single chamber ventricular pacemaker. QRS-Prä - ventricular conduction time bevor TAVI, HPD-Prä – heart period duration after TAVI, PQ-Prä – atrioventricular conduction time after TAVI, r, P – Pearson correlation coefficients.

valve implantation (Fig. 4) and after transcatheter aortic valve implantation (p < 0.01) (Fig. 5).

4 Conclusion

Electrical ventricular conduction times were prolonged after transcatheter aortic valve implantation in heart failure patients with permanent cardiac pacemaker therapy after transcatheter aortic valve implantation. QRS and QT ventricular conduction times may be useful non-invasive parameters to evaluate the risk of post-procedural prolongation of ventricular conduction times and permanent cardiac pacemaker therapy in transcatheter aortic valve implantation.

References

  • [1]

    P.C. Takam, J. Büttner, D. Höfflin, M. Heinke: Atrioventricular conduction time and permanent pacemaker therapy after transcatheter aortic valve implantation. Biomed. Tech 59, (Suppl.1) 2014, 410, S.224-S. 226, DOI 10.1515/bmt-2014-410 CrossrefGoogle Scholar

  • [2]

    K. Döbler, K. Boukamp, E. D. Mayer: Indikationstellungen, Strukturen und Prozess für die kathetergestüzte Aortenklappenimplantation; Zeitschrift für Herz-; Thorax- und Gefäßchirugie. Springer (2012) 26,398:86-96. Google Scholar

About the article

Published Online: 2015-09-12

Published in Print: 2015-09-01


Author’s Statement

Conflict of interest: Authors state no conflict of interest. Material and Methods: Informed consent: Informed consent has been obtained from all individuals included in this study. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.


Citation Information: Current Directions in Biomedical Engineering, Volume 1, Issue 1, Pages 124–126, ISSN (Online) 2364-5504, DOI: https://doi.org/10.1515/cdbme-2015-0032.

Export Citation

© 2015 by Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in